文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

3A 站淋巴结清扫术不能提高可手术的右侧非小细胞肺癌患者的长期生存率:一项倾向评分匹配研究。

Station 3A lymph node dissection does not improve long-term survival in right-side operable non-small-cell lung cancer patients: A propensity score matching study.

机构信息

Department of Thoracic Surgery, Sun Yat-sen University Cancer Center, Guangzhou City, Guangdong Province, China.

State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou City, Guangdong Province, China.

出版信息

Thorac Cancer. 2022 Aug;13(15):2106-2116. doi: 10.1111/1759-7714.14456. Epub 2022 Jun 15.


DOI:10.1111/1759-7714.14456
PMID:35702992
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9346165/
Abstract

BACKGROUND: To investigate the impact of station 3A lymph node dissection (LND) on overall survival (OS) and disease-free survival (DFS) in completely resected right-side non-small-cell lung cancer (NSCLC) patients. METHODS: A total of 1661 cases with completely resected right-side NSCLC were included. Propensity score matching (PSM) was performed to minimize selection bias, and a logistic regression model was conducted to investigate the risk factors associated with station 3A lymph node metastasis (LNM). The Kaplan-Meier method and Cox proportional hazards model were used to evaluate the impact of station 3A LND on survival. RESULTS: For the entire cohort, 503 patients (30.3%) underwent station 3A LND. Of those, 11.3% (57/503) presented station 3A LNM. Univariate and multivariate logistic analyses showed that station 10 LNM, tumor location, and the number of resected lymph nodes were independent risk factors associated with station 3A LNM. Before PSM, patients with station 3A LND had worse 5-year OS (p = 0.002) and DFS (p = 0.011), and more drainage on postoperative day 1 (p = 0.041) than those without. After PSM, however, station 3A LND was not associated with the 5-year OS (65.7% vs. 63.6%, p = 0.432) or DFS (57.4% vs. 56.0%, p = 0.437). The multivariate analysis further confirmed that station 3A LND was not a prognostic factor (OS, p = 0.361; DFS, p = 0.447). CONCLUSIONS: Station 3A LND could not improve long-term outcomes and it was unnecessary to dissect station 3A lymph nodes during surgery of right-side NSCLC.

摘要

背景:探讨完全切除的右侧非小细胞肺癌(NSCLC)患者的 3A 站淋巴结清扫术(LND)对总生存(OS)和无病生存(DFS)的影响。

方法:共纳入 1661 例完全切除的右侧 NSCLC 患者。采用倾向评分匹配(PSM)以最小化选择偏倚,并进行逻辑回归模型以探讨与 3A 站淋巴结转移(LNM)相关的危险因素。采用 Kaplan-Meier 方法和 Cox 比例风险模型评估 3A 站 LND 对生存的影响。

结果:对于整个队列,503 例患者(30.3%)接受了 3A 站 LND。其中,11.3%(57/503)存在 3A 站 LNM。单因素和多因素逻辑分析表明,10 站 LNM、肿瘤位置和切除的淋巴结数量是与 3A 站 LNM 相关的独立危险因素。在 PSM 之前,接受 3A 站 LND 的患者 5 年 OS(p=0.002)和 DFS(p=0.011)较差,术后第 1 天引流更多(p=0.041)。然而,PSM 后,3A 站 LND 与 5 年 OS(65.7% vs. 63.6%,p=0.432)或 DFS(57.4% vs. 56.0%,p=0.437)无关。多因素分析进一步证实,3A 站 LND 不是预后因素(OS,p=0.361;DFS,p=0.447)。

结论:3A 站 LND 不能改善长期预后,右侧 NSCLC 手术时无需解剖 3A 站淋巴结。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/689c/9346165/f2f4b68c9063/TCA-13-2106-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/689c/9346165/da5813839c4b/TCA-13-2106-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/689c/9346165/f2f4b68c9063/TCA-13-2106-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/689c/9346165/da5813839c4b/TCA-13-2106-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/689c/9346165/f2f4b68c9063/TCA-13-2106-g001.jpg

相似文献

[1]
Station 3A lymph node dissection does not improve long-term survival in right-side operable non-small-cell lung cancer patients: A propensity score matching study.

Thorac Cancer. 2022-8

[2]
Clinical Significance of Station 3A Lymph Node Dissection in Patients with Right-Side Non-Small-Cell Lung Cancer: A Retrospective Propensity-Matched Analysis.

Ann Surg Oncol. 2021-1

[3]
Impact of L4 lymph node dissection on long-term survival in left-side operable non-small-cell lung cancer: a propensity score matching study.

Eur J Cardiothorac Surg. 2020-6-1

[4]
The impact of station 4L lymph node dissection on short-term and long-term outcomes in non-small cell lung cancer.

Lung Cancer. 2022-8

[5]
Adequate lymph node dissection is essential for accurate nodal staging in intrahepatic cholangiocarcinoma: A population-based study.

Cancer Med. 2023-4

[6]
Prognostic role of station 3A mediastinal nodes for non-small-cell lung cancers.

Interact Cardiovasc Thorac Surg. 2013-9

[7]
The prognostic value of 4L lymph node dissection in left-side operable non-small-cell lung cancer: a meta-analysis.

Updates Surg. 2024-1

[8]
Prognostic significance of 4R lymph node dissection in patients with right primary non-small cell lung cancer.

World J Surg Oncol. 2022-7-1

[9]
Dissection of 4L lymph node for left-sided non-small cell lung cancer: a meta-analysis.

ANZ J Surg. 2021-11

[10]
Lobe-specific nodal dissection with intraoperative frozen section analysis for clinical stage-I non-small cell lung cancer: a validation study by propensity score matching.

Gen Thorac Cardiovasc Surg. 2022-11

引用本文的文献

[1]
PROX1 Expression in Resected Non-Small Cell Lung Cancer: Immunohistochemical Profile and Clinicopathological Correlates.

Med Sci (Basel). 2025-8-17

[2]
Impact of lymph node evaluation standard in patients undergoing lung resection for clinical stage IA pulmonary adenocarcinoma and squamous cell carcinoma.

J Thorac Dis. 2024-11-30

[3]
Application of tissue pneumoperitoneum technique around lymph nodes in thoracoscopic lung cancer resection.

Front Oncol. 2024-8-26

[4]
Mechanism insights and therapeutic intervention of tumor metastasis: latest developments and perspectives.

Signal Transduct Target Ther. 2024-8-2

本文引用的文献

[1]
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021.

J Natl Compr Canc Netw. 2021-3-2

[2]
Clinical Significance of Station 3A Lymph Node Dissection in Patients with Right-Side Non-Small-Cell Lung Cancer: A Retrospective Propensity-Matched Analysis.

Ann Surg Oncol. 2021-1

[3]
Impact of L4 lymph node dissection on long-term survival in left-side operable non-small-cell lung cancer: a propensity score matching study.

Eur J Cardiothorac Surg. 2020-6-1

[4]
The incidence and distribution of mediastinal lymph node metastasis and its impact on survival in patients with non-small-cell lung cancers 3 cm or less: data from 2292 cases.

Eur J Cardiothorac Surg. 2019-7-1

[5]
Incidence and Distribution of Lobe-Specific Mediastinal Lymph Node Metastasis in Non-small Cell Lung Cancer: Data from 4511 Resected Cases.

Ann Surg Oncol. 2018-8-6

[6]
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Ann Oncol. 2017-7-1

[7]
Long-term Survival Based on the Surgical Approach to Lobectomy For Clinical Stage I Nonsmall Cell Lung Cancer: Comparison of Robotic, Video-assisted Thoracic Surgery, and Thoracotomy Lobectomy.

Ann Surg. 2017-2

[8]
Impact of Examined Lymph Node Count on Precise Staging and Long-Term Survival of Resected Non-Small-Cell Lung Cancer: A Population Study of the US SEER Database and a Chinese Multi-Institutional Registry.

J Clin Oncol. 2017-4-10

[9]
The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer.

J Thorac Oncol. 2016-1

[10]
Is the lymphatic drainage of lung cancer lobe-specific? A surgical appraisal.

Eur J Cardiothorac Surg. 2015-3

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索